Novo Nordisk supports new global commitment to fight noncommunicable diseases
30 May 2013 | By Novo Nordisk
The World Health Assembly unanimously adopted a global action plan...
List view / Grid view
News
GSK strengthens vaccines business with acquisition of Okairos
29 May 2013 | By GlaxoSmithKline
GSK has acquired Okairos AG, a specialist developer of vaccine platform technologies for €250 million in cash...
Syrris videos show how to access the benefits of flow chemistry
29 May 2013 | By kdm communications limited
Syrris has produced an exciting series of online videos...
Biogen Idec reinforces commitment to MS community on 5th Annual World MS Day
29 May 2013 | By Biogen Idec
Biogen Idec Corporate website dedicated to World MS Day awareness...
World MS Day: Novartis launches a new campaign to raise awareness of MS
29 May 2013 | By Novartis
Novartis is joining the global multiple sclerosis community in celebration of World MS Day...
Amgen and Astellas announce Japan alliance
29 May 2013 | By Amgen
Innovative joint venture to address unmet medical needs of patients in Japan...
Two new GSK oral oncology treatments approved by FDA
29 May 2013 | By GlaxoSmithKline
BRAF-inhibitor Tafinlar® (dabrafenib) capsules and the first MEK-inhibitor Mekinist™ (trametinib) tablets approved by FDA...
GSK and Genmab announce positive top-line results from pivotal trial of ARZERRA® (ofatumumab) combined with chlorambucil in previously untreated chronic lymphocytic leukaemia
29 May 2013 | By GlaxoSmithKline
"We are delighted with the positive results..."
European Commission approves Stribild®
28 May 2013 | By Gilead Sciences
Gilead Sciences announced that the European Commission has granted marketing authorization for Stribild®...
New European survey highlights ischaemic stroke protection as treatment priority for patients with atrial fibrillation
28 May 2013 | By Boehringer Ingelheim
Findings from a pan-European online survey...
AstraZeneca to acquire Omthera Pharmaceuticals
28 May 2013 | By AstraZeneca
AstraZeneca announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals...
Boehringer Ingelheim and Eli Lilly & Company launch type 2 diabetes educational game, “Complications Combat”
24 May 2013 | By Boehringer Ingelheim
"The aim and design of the game is simple..."
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
23 May 2013 | By Biogen Idec
Biogen Idec announced that Spyros Artavanis-Tsakonas, Ph.D., has been named the company’s Chief Scientific Officer...
GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics
23 May 2013 | By GlaxoSmithKline
Funding will support development of drugs to fight antibiotic resistance and bioterrorism...
Sanofi appoints David Loew, Senior Vice President, Commercial Operations, Europe
23 May 2013 | By Sanofi
Sanofi is pleased to announce the appointment of David Loew, effective July 1st , 2013.
